PLUS1
0.4151
-0.0549 (-11.68%)
-0.0549 (-11.68%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,002,723 |
|
|||||
| News | - | ||||||
| Day High | 0.47 | Low High |
|||||
| Day Low | 0.4095 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
USA Small Cap Basic
Monthly Subscription
for only
|
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aileron Therapeutics Inc | ALRN | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
 |
|
|---|---|---|---|---|
| -0.0549 | -11.68% | 0.4151 | 11:49:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.45 | 0.4095 | 0.47 | 0.4151 | 0.47 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,818 | 1,002,723 | US$ 0.4271358 | US$ 428,299 | - | 0.4095 - 2.33 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:22:55 | 40 | US$ 0.435 | USD |
Period:
Draw Mode:
Aileron Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 37.60M | 90.57M | 71.32M | US$ - | US$ - | -0.63 | -1.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 1.40% |
Aileron Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 06/1/2022 | 02:06 | TipRanks | H.C. Wainwright Thinks Aileron Therapeutics’ Stock is Going.. |
| 06/1/2022 | 01:05 | Seeking Alpha | Aileron Therapeutics outlines 2022 strategic priorities to.. |
| 21/12/2021 | 02:56 | GlobeNewswire Inc. | Aileron Therapeutics Issues Statement on Passing of.. |
| 08/12/2021 | 08:30 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 25/11/2021 | 20:11 | TipRanks | JonesTrading Maintains Their Buy Rating on Aileron.. |
| 12/11/2021 | 23:57 | Seeking Alpha | Aileron Therapeutics EPS in-line |
| 17/9/2021 | 22:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 13/9/2021 | 20:56 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 07/9/2021 | 02:10 | Seeking Alpha | 5 biotech names ready for a comeback- Barron's |
| 12/8/2021 | 06:03 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 01/7/2021 | 22:32 | Seeking Alpha | Aileron Therapeutics launches ALRN-6924 trial in patients.. |
| 18/6/2021 | 09:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
Historical ALRN Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.50 | 0.5047 | 0.4095 | 0.4618001 | 245,578 | -0.0849 | -16.98% |
| 1 Month | 0.55 | 0.609899 | 0.4095 | 0.5239278 | 405,065 | -0.1349 | -24.53% |
| 3 Months | 0.8585 | 0.9399 | 0.4095 | 0.6387998 | 459,639 | -0.4434 | -51.65% |
| 6 Months | 1.08 | 1.27 | 0.4095 | 0.9046819 | 520,830 | -0.6649 | -61.56% |
| 1 Year | 1.9394 | 2.33 | 0.4095 | 1.50 | 1,033,410 | -1.52 | -78.6% |
| 3 Years | 1.21 | 2.60 | 0.25 | 1.36 | 867,196 | -0.7949 | -65.69% |
| 5 Years | 13.75 | 15.48 | 0.25 | 1.53 | 597,420 | -13.33 | -96.98% |
